NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
02/22/2024
Back to search
Official data from USPTO
COLORADO THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
02/22/2024
Trademark type
Combined
Nice classes
10
Filing date
02/20/2016
Registration date
11/28/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/22/2024
Last transaction
02/22/2024
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2017-04-00
First use in commerce
2017-04-00
Drawing code
3
Owner type
16
Owner location
Louisville, CO
Examiner
KELLY, JOHN
Law office
N10
Current location
TMO LAW OFFICE 119
Mark description
The mark consists of a shaded half circle with a shaded circle centered to the right and the word "COLORADO" to the right of the design with the word "THERAPEUTICS" lined up below the word "COLORADO".
Holders and representatives
Holders
Colorado Therapeutics LLC
Colorado Therapeutics LLC
Representatives
Emily A. Bayton FAEGRE DRINKER BIDDLE & REATH LLP
Technical classification
Nice Classes
Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 10
Surgical implants comprised of non-living tissues; surgical implants comprised of non-living tissue for hernia repair and soft tissue repair procedures; non-living biological xenograft tissue intended for subsequent implantation; non-living biological tissue grafts; medical productsxenografts comprised of non-living tissue for the reconstruction and repair of pericardial tissue defectscardiac patchesheart valve repairvascular grafts; vascular grafts of non-living tissue; flexible surgical implants comprised of non-living tissue; non-living biological tissue intended for subsequent surgical and medical implantation for the treatment of soft tissue defectsreconstructionrepair of human tissue
Publications
History of USPTO decisions and trademark events.
29 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
02/22/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/22/2024
E815
TEAS SECTION 8 & 15 RECEIVED
09/06/2023
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
11/28/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
11/28/2017
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
10/27/2017
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
10/26/2017
SUPC
STATEMENT OF USE PROCESSING COMPLETE
10/11/2017
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
10/08/2017
IUAF
USE AMENDMENT FILED
10/04/2017
EISU
TEAS STATEMENT OF USE RECEIVED
10/04/2017
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
04/04/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/07/2017
PUBO
PUBLISHED FOR OPPOSITION
02/07/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/18/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/27/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/16/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/15/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/15/2016
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/14/2016
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/14/2016
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/17/2016
GNRT
NON-FINAL ACTION E-MAILED
06/17/2016
CNRT
NON-FINAL ACTION WRITTEN
06/17/2016
DOCK
ASSIGNED TO EXAMINER
06/06/2016
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
02/26/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/25/2016
NWAP
NEW APPLICATION ENTERED
02/24/2016
Continuous trademark protection
Get notified about every new filing that threatens COLORADO THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.